Malaria Ag Rapid Testing Market Share

  • Report ID: 5547
  • Published Date: Jan 03, 2025
  • Report Format: PDF, PPT

Malaria Ag Rapid Testing Industry - Regional Synopsis

North American Market Forecast

North America industry is predicted to account for largest revenue share of 30% by 2037. This growth is set to be dominated by rising travelers returning to North America. Furthermore, with about 45% of US corporate travelers doing more trips than they did prior to the epidemic, business travel is returning. However, this has further led to an increase in malaria cases. Most of the people in North America visit regions such as the Middle East & Africa which is the hotspots for malaria prevalence. Hence, these travelers return back with the infection hence boosting the malaria rate. Every year, travel to malaria-endemic regions including sub-Saharan Africa, parts of South America, and Southeast Asia is linked to between 1,999 and 2,500 cases of malaria in the country; nevertheless, over 8 locally transmitted cases this year have been reported by individuals who haven't recently visited these regions. There were about 6 instances reported in Florida and one in each of Maryland and Texas. Hence, it has also been estimated that this region has recorded its first homegrown malaria cases. Therefore, the market for malaria ag rapid testing market is set to rise in this region.

European Market Analysis

The malaria ag rapid testing market in Europe is also expected to experience significant growth over the forecast period. Fifty years after being eradicated, malaria remains a serious health threat in Europe. Furthermore, there has been rigorous launch of vaccines in this region by various key players and number of researches has taken place in order to eradicate completely. As a result, this market is poised to grow in this region.

Malaria Ag Rapid Testing Market overview

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of malaria ag rapid testing is assessed at USD 38.44 billion.

The malaria ag rapid testing market size was over USD 36.93 billion in 2024 and is projected to reach USD 67.93 billion by 2037, growing at around 4.8% CAGR during the forecast period i.e., between 2025-2037. The market growth is impelled by surge in adoption of latest technology, rise in government initiatives for the awareness regarding malaria, and extreme weather event to increase prevalence of malaria.

North America industry is predicted to account for largest revenue share of 30% by 2037, due to rising travelers returning to North America.

The major players in the market are Wyss Institute, Novartis AG, Alere, Inc., Nectar Lifesciences Ltd., and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos